Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer (RPGOG1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01048320
Recruitment Status : Completed
First Posted : January 13, 2010
Last Update Posted : September 25, 2012
Information provided by:
Royal Marsden NHS Foundation Trust

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : December 2010